AU2259999A - Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation - Google Patents

Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Info

Publication number
AU2259999A
AU2259999A AU22599/99A AU2259999A AU2259999A AU 2259999 A AU2259999 A AU 2259999A AU 22599/99 A AU22599/99 A AU 22599/99A AU 2259999 A AU2259999 A AU 2259999A AU 2259999 A AU2259999 A AU 2259999A
Authority
AU
Australia
Prior art keywords
hepatic
oxygenation
reversal
aging
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22599/99A
Inventor
David George Le Couteur
Allan Joseph Mclean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP1542A external-priority patent/AUPP154298A0/en
Priority claimed from AUPP7619A external-priority patent/AUPP761998A0/en
Priority claimed from AUPP7701A external-priority patent/AUPP770198A0/en
Application filed by Individual filed Critical Individual
Priority to AU22599/99A priority Critical patent/AU2259999A/en
Priority claimed from PCT/AU1999/000065 external-priority patent/WO1999038507A1/en
Publication of AU2259999A publication Critical patent/AU2259999A/en
Abandoned legal-status Critical Current

Links

AU22599/99A 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation Abandoned AU2259999A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22599/99A AU2259999A (en) 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
AUPP1542A AUPP154298A0 (en) 1998-01-30 1998-01-30 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP1542 1998-01-30
AUPP7619A AUPP761998A0 (en) 1998-12-09 1998-12-09 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AUPP7619 1998-12-09
AUPP7701 1998-12-11
AUPP7701A AUPP770198A0 (en) 1998-12-11 1998-12-11 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AU22599/99A AU2259999A (en) 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
PCT/AU1999/000065 WO1999038507A1 (en) 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Publications (1)

Publication Number Publication Date
AU2259999A true AU2259999A (en) 1999-08-16

Family

ID=27422725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22599/99A Abandoned AU2259999A (en) 1998-01-30 1999-02-01 Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation

Country Status (1)

Country Link
AU (1) AU2259999A (en)

Similar Documents

Publication Publication Date Title
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
AU1606900A (en) Non-electrolytic gold plating compositions and methods of use thereof
AU1920900A (en) Solid water treatment composition and methods of preparation and use
PL342892A1 (en) Remineralization of teeth
HUP0002493A3 (en) Use of colchinol derivatives as vascular damaging agents and certain new compounds
EP1076547A4 (en) Derivatives of arabinogalactan and compositions including the same
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
AU3118499A (en) Soft tissue reconstructor and method of use
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
IL138672A0 (en) Liposomal bupivacaine compositions and methods of preparation
AU3671999A (en) Combination of main scrubbing machine and attachment scrubbing machine
AU7277798A (en) Use of sialyl galactosides and related compounds as anti-angiogenic agents
AU6412599A (en) Oxybutynin formulations and methods of use
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
AU2259999A (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP154298A0 (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AUPP770198A0 (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AUPP761998A0 (en) Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
AU6593100A (en) Interdental brush and interdental brush set
AU3964499A (en) Agouti-related protein analogs and methods of use
AU5226798A (en) Use of paracetamol as depigmenting agent
AU3774100A (en) Heat-activated cleaning compositions with wrinkle-resistance and methods of use
TW406556U (en) Improvement of dental floss structure
AU4207899A (en) Lentiviral vector compositions and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase